Get the Stockscreener App
314.56
0.01%
0.04
After Hours:
314.56
Insulet Corporation stock is traded at $314.56, with a volume of 462.70K.
It is up +0.01% in the last 24 hours and down -7.96% over the past month.
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.
See More
Previous Close:
$314.52
Open:
$314.43
24h Volume:
462.70K
Relative Volume:
0.74
Market Cap:
$22.14B
Revenue:
$2.36B
Net Income/Loss:
$236.10M
P/E Ratio:
95.73
EPS:
3.286
Net Cash Flow:
$382.50M
1W Performance:
+0.92%
1M Performance:
-7.96%
6M Performance:
+23.85%
1Y Performance:
+34.95%
1-Day Range:
$312.10
$317.53
1-Week Range:
$310.02
$324.69
52-Week Range:
$226.50
$353.50
Insulet Corporation Stock (PODD) Company Profile
Name
Insulet Corporation
Sector
Industry
Phone
978-600-7000
Address
100 NAGOG PARK, ACTON, MA
Compare PODD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PODD
Insulet Corporation
|
314.56 | 22.14B | 2.36B | 236.10M | 382.50M | 3.286 |
|
ABT
Abbott Laboratories
|
131.38 | 230.73B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
94.95 | 141.37B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.92 | 139.39B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.58 | 122.43B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
72.95 | 43.41B | 5.69B | 1.41B | 577.90M | 6.9828 |
Insulet Corporation Stock (PODD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-08-25 | Resumed | Oppenheimer | Outperform |
| Jun-16-25 | Initiated | Truist | Buy |
| May-30-25 | Initiated | Goldman | Buy |
| May-13-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Apr-29-25 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Mar-06-25 | Initiated | RBC Capital Mkts | Outperform |
| Nov-06-24 | Initiated | Bernstein | Outperform |
| May-30-24 | Initiated | Redburn Atlantic | Buy |
| May-07-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-21-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-04-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-02-23 | Upgrade | Jefferies | Hold → Buy |
| Aug-21-23 | Upgrade | Citigroup | Neutral → Buy |
| Aug-21-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Jan-26-23 | Initiated | Wolfe Research | Peer Perform |
| Nov-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-11-22 | Downgrade | Citigroup | Buy → Neutral |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-03-22 | Upgrade | BTIG Research | Neutral → Buy |
| Feb-02-22 | Upgrade | UBS | Neutral → Buy |
| Jan-31-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Jul-21-21 | Resumed | Cowen | Outperform |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-01-21 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Mar-19-21 | Upgrade | Canaccord Genuity | Hold → Buy |
| Jan-29-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
| Jul-28-20 | Initiated | Wells Fargo | Overweight |
| Apr-24-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-03-20 | Initiated | BofA/Merrill | Neutral |
| Mar-31-20 | Downgrade | Berenberg | Buy → Hold |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Dec-10-19 | Initiated | CFRA | Sell |
| Oct-23-19 | Initiated | Stifel | Hold |
| Oct-18-19 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-14-19 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-04-19 | Downgrade | UBS | Buy → Neutral |
| Oct-03-19 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-06-19 | Upgrade | JP Morgan | Neutral → Overweight |
| Jun-10-19 | Downgrade | Northland Capital | Outperform → Market Perform |
| May-06-19 | Upgrade | BTIG Research | Neutral → Buy |
| Apr-20-18 | Initiated | Berenberg | Buy |
| Feb-22-18 | Reiterated | Barclays | Overweight |
| Jan-08-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-03-17 | Upgrade | Canaccord Genuity | Hold → Buy |
| Sep-15-17 | Initiated | Barclays | Overweight |
View All
Insulet Corporation Stock (PODD) Latest News
Pattern recognition hints at Insulet Corporation upsideQuarterly Market Review & Fast Gain Stock Trading Tips - newser.com
Insulet to Host Investor Day on November 20, 2025 - MarketScreener
How to monitor Insulet Corporation with trend dashboardsWeekly Trade Report & Community Consensus Picks - newser.com
What Fibonacci levels say about Insulet Corporation reboundPortfolio Risk Summary & Fast Gaining Stock Strategy Reports - newser.com
Lobbying Update: $50,000 of INSULET CORPORATION lobbying was just disclosed - Quiver Quantitative
Insulet names new CEO, plans to lift full year guidance - MSN
Fifth Third Wealth Advisors LLC Invests $448,000 in Insulet Corporation $PODD - MarketBeat
Insulet Corporation $PODD Shares Sold by Aberdeen Group plc - MarketBeat
Insulet Corporation (PODD) Stock Analysis: Exploring a 15.3% Potential Upside with Robust Growth Prospects - DirectorsTalk Interviews
How to interpret RSI for Insulet Corporation stockEarnings Risk Summary & Smart Investment Allocation Insights - newser.com
Long term hold vs stop loss in Insulet CorporationCEO Change & Weekly Watchlist for Hot Stocks - newser.com
Insulet Corporation stock trend outlook and recovery pathDividend Hike & Long-Term Growth Plans - newser.com
Insulet Corp. stock underperforms Tuesday when compared to competitors - MSN
Royal Bank Of Canada Raises Insulet (NASDAQ:PODD) Price Target to $365.00 - MarketBeat
Katamaran Capital LLP Has $1.22 Million Stock Position in Insulet Corporation $PODD - MarketBeat
Insulet (PODD) Valuation: Is There More Room to Run After 22% YTD Gain? - Yahoo Finance
Why analysts remain bullish on Insulet Corporation stockTrade Analysis Report & Daily Risk Controlled Trade Plans - newser.com
What MACD signals say about Insulet CorporationJuly 2025 EndofMonth & Community Consensus Stock Picks - newser.com
What RSI levels show for Insulet Corporation (GOV) stockQuarterly Profit Summary & Daily Volume Surge Signals - newser.com
RBC Lifts Price Target on Insulet to $365 From $350, Keeps Outperform Rating - MarketScreener
Blair William & Co. IL Sells 13,724 Shares of Insulet Corporation $PODD - MarketBeat
Truist Securities Reiterates Buy Rating on Insulet (PODD) Stock - MSN
Forecasting Insulet Corporation price range with options dataJuly 2025 Highlights & Reliable Entry Point Trade Alerts - newser.com
Is now a turning point for Insulet CorporationJuly 2025 Big Picture & AI Optimized Trade Strategies - newser.com
Insulet (NASDAQ:PODD) Earns "Hold (C)" Rating from Weiss Ratings - MarketBeat
Insulet Opens Global Capability Center in Guadalajara - Mexico Business News
Insulet Corp. Experiences Evaluation Revision Amidst Mixed Market Dynamics and Strong Performance - Markets Mojo
Is Insulet (PODD) a Solid Growth Stock? 3 Reasons to Think "Yes" - sharewise.com
Insulet Corporation $PODD Shares Sold by SGL Investment Advisors Inc. - MarketBeat
Real time scanner hits for Insulet Corporation explainedRisk Management & Technical Pattern Alert System - newser.com
Highland Capital Management LLC Makes New Investment in Insulet Corporation $PODD - MarketBeat
Insulet (PODD): A Fresh Look at Valuation Following Raised Guidance and Strong Q2 Growth - simplywall.st
How sentiment analysis helps forecast Insulet CorporationMarket Weekly Review & Fast Moving Market Watchlists - newser.com
Insulet Corporation $PODD Shares Acquired by ASR Vermogensbeheer N.V. - MarketBeat
What Analyst Watch Lists Suggest About Simplex Infrastructures Limiteds MomentumEarnings Revision Updates & Minimal Investment Trading Tips - earlytimes.in
Insulet (NASDAQ:PODD) Given New $370.00 Price Target at Rothschild & Co Redburn - MarketBeat
Franklin Street Advisors Inc. NC Makes New Investment in Insulet Corporation $PODD - MarketBeat
How Investors Are Reacting To Insulet (PODD) Raising Guidance After Surging Q2 Revenue and New Product Launch - simplywall.st
Rothschild & Co Redburn Adjusts Price Target on Insulet to $370 From $350, Maintains Buy Rating - MarketScreener
Can Omnipod Mango’s Bold Design Shift Signal a New Strategy for Insulet (PODD)? - simplywall.st
Lecap Asset Management Ltd. Takes Position in Insulet Corporation $PODD - MarketBeat
Robeco Institutional Asset Management B.V. Buys 119,786 Shares of Insulet Corporation $PODD - MarketBeat
Insulet Corporation $PODD Shares Purchased by Janney Montgomery Scott LLC - MarketBeat
Is Insulet Corporation (GOV) stock a buy for dividend portfoliosJuly 2025 Breakouts & Reliable Price Breakout Alerts - newser.com
Insulet Corporation stock retracement – recovery analysisEarnings Risk Summary & High Accuracy Trade Signal Alerts - newser.com
Will Insulet Corporation (GOV) stock deliver stable dividendsForecast Cut & AI Based Buy and Sell Signals - newser.com
Insulet Corporation Stock (PODD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.15%
0.12%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):